【ScinoPharm】Important Resolutions of the 115 Annual General Shareholders' Meeting

Key facts

  • 【ScinoPharm】Important Resolutions of the 115 Annual General Shareholders' Meeting
  • ScinoPharm held its Annual General Shareholders' Meeting on May 27, 115, approving a cash dividend of 0.29 TWD per share for the 114 fiscal year. The meeting also passed amendments to the Articles of Incorporation, asset disposal procedures, and the lifting of non-compete restrictions for directors.
  • Source: PR Times
  • Date: May 27, 2026

Direct answer

ScinoPharm held its Annual General Shareholders' Meeting on May 27, 115, approving a cash dividend of 0.29 TWD per share for the 114 fiscal year. The meeting also passed amendments to the Articles of Incorporation, asset disposal procedures, and the lifting of non-compete restrictions for directors.

Citation
【ScinoPharm】Important Resolutions of the 115 Annual General Shareholders' Meeting (May 27, 2026), PR Times
Source
PR Times
Date
May 27, 2026
ScinoPharm held its Annual General Shareholders' Meeting on May 27, 115, approving a cash dividend of 0.29 TWD per share for the 114 fiscal year. The meeting also passed amendments to the Articles of Incorporation, asset disposal procedures, and the lifting of non-compete restrictions for directors.
financeNQ 49/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: May 27, 2026 at 09:00
  • 🔍 Collected: May 28, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 31, 2026 at 18:51 (82h 51m after Collected)
1. Date of AGM: 115/05/27. 2. Earnings distribution: Approved the 114 earnings distribution plan, with a cash dividend of 0.29 TWD per share. 3. Articles of Incorporation: Approved amendments. 4. Business report and financial statements: Approved the 114 business report and financial statements. 5. Election of directors/supervisors: None. 6. Other matters: (1) Approved amendments to the 'Procedures for Acquisition or Disposal of Assets'. (2) Approved the lifting of non-compete restrictions for directors (including independent directors) and their representatives. 7. Other notes: None.

FAQ

When will the dividends be paid?

The specific payment date will be announced separately by the company.

What does lifting non-compete restrictions mean?

It allows directors to hold positions in other companies, facilitating broader industry collaboration.

What are the key facts in this article?

ScinoPharm held its Annual General Shareholders' Meeting on May 27, 115, approving a cash dividend of 0.29 TWD per share for the 114 fiscal year. The meeting also passed amendments to the Articles of Incorporation, asset disposal procedures, and the lifting of non-compete restrictions for directors.

Back to Newsroom (62)